Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease.

Usman Maqsood, Terence N Ho, Karen Palmer, Fiona JR Eccles, Mohammed Munavvar, Ran Wang, Iain Crossingham, David JW Evans

Research output: Contribution to journalArticlepeer-review

Abstract

Systematic Review
Original languageEnglish
JournalCochrane Database of Systematic Reviews
DOIs
Publication statusPublished - 6 Mar 2019

Fingerprint

Dive into the research topics of 'Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease.'. Together they form a unique fingerprint.

Cite this